DRviaSPCN (Q113676): Difference between revisions

← Older edit

@@ Property / last update @@
-March 2022Timestamp +2022-03-03T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2022-03-03T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / last update: 3 March 2022 / rank @@
-Normal rank
@@ Property / imports @@
-graphics
@@ Property / imports: graphics / rank @@
-Normal rank
@@ Property / imports @@
-igraph
@@ Property / imports: igraph / rank @@
-Normal rank
@@ Property / imports @@
-stats
@@ Property / imports: stats / rank @@
-Normal rank
@@ Property / imports @@
-ChemmineR
@@ Property / imports: ChemmineR / rank @@
-Normal rank
@@ Property / imports @@
-clusterProfiler
@@ Property / imports: clusterProfiler / rank @@
-Normal rank
@@ Property / imports @@
-pheatmap
@@ Property / imports: pheatmap / rank @@
-Normal rank
@@ Property / imports @@
-rvest
@@ Property / imports: rvest / rank @@
-Normal rank
@@ Property / imports @@
-xml2
@@ Property / imports: xml2 / rank @@
-Normal rank
@@ Property / software version identifier @@
+.1.0
@@ Property / software version identifier: 0.1.0 / rank @@
+Normal rank
@@ Property / software version identifier: 0.1.0 / qualifier @@
+publication date: 9 December 2021Timestamp +2021-12-09T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2021-12-09T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / software version identifier @@
+.1.1
@@ Property / software version identifier: 0.1.1 / rank @@
+Normal rank
@@ Property / software version identifier: 0.1.1 / qualifier @@
+publication date: 28 February 2022Timestamp +2022-02-28T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2022-02-28T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / software version identifier @@
+.1.3
@@ Property / software version identifier: 0.1.3 / rank @@
+Normal rank
@@ Property / software version identifier: 0.1.3 / qualifier @@
+publication date: 25 September 2023Timestamp +2023-09-25T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2023-09-25T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / software version identifier @@
+.1.4
@@ Property / software version identifier: 0.1.4 / rank @@
+Normal rank
@@ Property / software version identifier: 0.1.4 / qualifier @@
+publication date: 13 January 2024Timestamp +2024-01-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2024-01-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / last update @@
+January 2024Timestamp +2024-01-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2024-01-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / last update: 13 January 2024 / rank @@
+Normal rank
@@ Property / description @@
+A systematic biology tool was developed to repurpose drugs via a subpathway crosstalk network. The operation modes include 1) calculating centrality scores of SPs in the context of gene expression data to reflect the influence of SP crosstalk, 2) evaluating drug-disease reverse association based on disease- and drug-induced SPs weighted by the SP crosstalk, 3) identifying cancer candidate drugs through perturbation analysis. There are also several functions used to visualize the results.
+Normal rank
@@ Property / author @@
+Junwei Han
@@ Property / author: Junwei Han / rank @@
+Normal rank
@@ Property / author @@
+Jiashuo Wu
@@ Property / author: Jiashuo Wu / rank @@
+Normal rank
@@ Property / copyright license @@
+GNU General Public License, version 2.0
@@ Property / copyright license: GNU General Public License, version 2.0 / rank @@
+Normal rank
@@ Property / copyright license @@
+GNU General Public License, version 3.0
@@ Property / copyright license: GNU General Public License, version 3.0 / rank @@
+Normal rank
+edition/version: expanded from: GPL (≥ 2) (English)
@@ Property / imports @@
+GSVA
@@ Property / imports: GSVA / rank @@
+Normal rank
@@ Property / imports @@
+clusterProfiler
@@ Property / imports: clusterProfiler / rank @@
+Normal rank
@@ Property / imports @@
+graphics
@@ Property / imports: graphics / rank @@
+Normal rank
@@ Property / imports @@
+igraph
@@ Property / imports: igraph / rank @@
+Normal rank
@@ Property / imports @@
+pheatmap
@@ Property / imports: pheatmap / rank @@
+Normal rank
@@ Property / imports @@
+stats
@@ Property / imports: stats / rank @@
+Normal rank
@@ Property / imports @@
+sp
@@ Property / imports: sp / rank @@
+Normal rank
@@ Property / imports @@
+ChemmineR
@@ Property / imports: ChemmineR / rank @@
+Normal rank
@@ Property / depends on software @@
+R
@@ Property / depends on software: R / rank @@
+Normal rank
@@ Property / depends on software: R / qualifier @@
+software version identifier: ≥ 3.6
@@ Property / MaRDI profile type @@
+MaRDI software profile
@@ Property / MaRDI profile type: MaRDI software profile / rank @@
+Normal rank
@@ links / mardi / name / links / mardi / name @@
+Software:113676

Latest revision as of 18:55, 12 March 2024

Drug Repurposing in Cancer via a Subpathway Crosstalk Network

Language	Label	Description	Also known as
English	DRviaSPCN	Drug Repurposing in Cancer via a Subpathway Crosstalk Network

Statements

instance of

R package

0 references

software version identifier

0.1.2

publication date

3 March 2022

0 references

0.1.0

publication date

9 December 2021

0 references

0.1.1

publication date

28 February 2022

0 references

0.1.3

publication date

25 September 2023

0 references

0.1.4

publication date

13 January 2024

0 references

0 references

0 references

13 January 2024

0 references

description

A systematic biology tool was developed to repurpose drugs via a subpathway crosstalk network. The operation modes include 1) calculating centrality scores of SPs in the context of gene expression data to reflect the influence of SP crosstalk, 2) evaluating drug-disease reverse association based on disease- and drug-induced SPs weighted by the SP crosstalk, 3) identifying cancer candidate drugs through perturbation analysis. There are also several functions used to visualize the results.

0 references

0 references

0 references

GNU General Public License, version 2.0

0 references

GNU General Public License, version 3.0

edition/version

expanded from: GPL (≥ 2) (English)